UnitedHealth Group

When the Federal Trade Commission (FTC) officially accused the three largest PBMs of artificially inflating insulin prices, it marked the latest move in what has become a protracted effort by federa

UnitedHealth Group saw “rapid acceleration in the prescribing of certain high-cost specialty medications” in its Medicare Advantage prescription drug plans in the third quarter. Prescribing increased

Effective obesity drugs were a long time coming, but they have arrived amid a flurry of other treatment innovations, from new migraine therapies to gene therapies for sickle cell disease. This, combin

Managed care organizations are reeling from a bolus of post-pandemic medical procedures hitting their bottom line. This will not continue forever, but the aging of the US population is a less ephemera